MICROOMIX
Description:
MicroOmix is developing a solution for high-throughput screening of cells according to the molecules they secrete. This solution is based on a proprietary and patented detection system that allows the messages sent by each cell to be read individually. It allows the isolation and recovery of living cells responding to a targeted biological function, opening up a new and expressive path of discovery in the fields of antibodies, immuno-oncology, and cellular therapies...
MicroOmix aims to develop an instrument and consumable kits that will provide simple and affordable solutions to the growing needs of the Biomedical research and industry in the development of therapeutic antibodies and cell therapies.
At the origin of the project
Alain WAGNER
Director of the Biofunctional Chemistry team at the CAMB laboratory in Strasbourg (UMR 7199, CNRS et University of Strasbourg).
+
Institut du Médicament de Strasbourg and IMCBio